Among the stories that have emerged over the last twenty years in this age of psychopharmacology, few are as strange as the story of John Rush who was in the Department of Psychiatry at the University of Texas Southwestern for thirty years. Early on, he had studied Cognitive Behavior Therapy with Aaron Beck but not […]
Whistleblower Claims Forest Bribed Study’s Investigator to Favor Celexa Bloomberg By John T. Aquino February 1, 2012 A whistleblower’s complaint from 2011 that was unsealed Jan. 20 in a federal district court alleged that Forest Pharmaceuticals paid the principal investigator of a federally funded antidepressant drug study to fix the results in favor of the […]
In response to a request from Senator Grassley, the Government Accountability Office did a survey [12/01/2011] of the medication of Medicaid covered children with psychotropic drugs in five States [Florida, Texas, Oregon, Michigan, and Massachusetts], separating Foster Children and non-Foster Children: Medicaid – Foster Children Age FL TX OR MI MA 0-5 5.3% […]
The two drugs under consideration here are RISPERDAL® CONSTA®, an injectable version of Risperdal [monthly] approved by the FDA in 2003, and INVEGA® SUSTENNA®, an injectable version of PALIPERIDONE PALMITATE [9-hydroxy-risperidone] with a different delivery system approved by the FDA in 2009. Janssen has launched a campaign to help patients use their injectable drugs […]
That ad in the last post for VITAL™ doesn’t say what it’s for, but this does: Janssen® Connect™ Launches In California New Service Helps Practitioners Coordinate Care for Patients Receiving Company’s Long-Acting Injectable Therapies Titusville, NJ (January 31, 2011) – Janssen®, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., announced today the launch in California of Janssen® Connect™, […]